• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Volt Information Science

Volt Information Science

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Alexion Receives CHMP Positive Opinions for Strensiq™ (asfotase alfa) and Kanuma™ (sebelipase alfa) in the European Union

    Alexion Receives CHMP Positive Opinions for Strensiq™ (asfotase alfa) and Kanuma™ (sebelipase alfa) in the European Union

  2. Global Diversification With a Smoother Ride

    Although this low-volatility global equity ETF holds U.S. stocks, it has offered more diversification from the S&P 500 than the average world-stock fund.

  3. AM-Pharma Receives FDA and EMA Orphan Drug Designation to Treat Hypophosphatasia

    AM-Pharma Receives FDA and EMA Orphan Drug Designation to Treat Hypophosphatasia

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.